Chapter 2: Cardiovascular system

Recommended for primary and secondary prevention in patients at high risk of CVD

CAUTION: Rhabomyolysis: Check interactions (e.g. fibrates, dihydropyridines, antiinfectives)

Consider need for and intensity of treatment in light of life expectancy and ADR risk